This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
What Is Behind Zumiez's Continued Comparable Sales Growth Streak?
by Zacks Equity Research
ZUMZ posts its fourth straight quarter of comp sales growth, fueled by pricing gains and strong North America demand.
What's Behind Zumiez's Gross Margin Growth Amid Tariff Pressures?
by Zacks Equity Research
ZUMZ lifts gross margin to 30% through full-price selling, private label growth and sharp cost discipline.
ZUMZ Posts Wider-Than-Expected Q1 Loss, 5.5% Y/Y Rise in Comps
by Zacks Equity Research
Zumiez posts a wider-than-expected Q1 loss. Comps jump 5.5% Y/Y as North America and women's categories shine.
Zumiez (ZUMZ) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Zumiez (ZUMZ) delivered earnings and revenue surprises of -2.60% and 0.99%, respectively, for the quarter ended April 2025. Do the numbers hold clues to what lies ahead for the stock?
ZUMZ Trades Near 52-Week Low: Time to Buy, Hold or Sell the Stock?
by Zacks Equity Research
Zumiez faces demand and global headwinds. Yet, margin gains, cost control and private label growth highlight its strategic progress.
Zumiez Q4 Earnings & Sales Miss Estimates, Comps Increase Y/Y
by Zacks Equity Research
ZUMZ's fiscal fourth-quarter results reflect lower y/y sales. However, the gross margin expands 190 bps y/y to 36.2%.
Zumiez (ZUMZ) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Zumiez (ZUMZ) delivered earnings and revenue surprises of -1.27% and 0.62%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
Vera Bradley (VRA) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Vera Bradley (VRA) delivered earnings and revenue surprises of -400% and 11.54%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
Genesco (GCO) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Genesco (GCO) delivered earnings and revenue surprises of -1.51% and 4.96%, respectively, for the quarter ended January 2025. Do the numbers hold clues to what lies ahead for the stock?
Is Zumiez Stock a Buy, Hold or Sell Post Holiday Sales Results?
by Zacks Equity Research
Zumiez's expansion of private-label products, new brands and focus on cost efficiency position it for growth despite recent challenges.
Zumiez Revises Q4 Forecast Amid Lower-Than-Expected Holiday Results
by Zacks Equity Research
Zumiez reports solid growth but lowers fiscal fourth-quarter guidance due to weaker holiday sales. However, it stays optimistic about growth in fiscal 2025 and beyond.
ZUMZ Boosts its Position With Brand Expansion & Private-Label Growth
by Zacks Equity Research
With a strategic focus on cost management, Zumiez is positioned for growth, expecting improvements in sales and margins moving forward.
ZUMZ Gains From Customer Engagement: Key Factors to Consider
by Zacks Equity Research
Zumiez is expanding its brand portfolio and private label offerings to boost customer engagement. A positive outlook for 2024 is encouraging.
Zumiez Beats on Q3 Earnings, Strong Comparable Sales Drive Revenues
by Zacks Equity Research
ZUMZ Q3 results reflect strong North America sales with 2.9% growth and positive comps. However, international performance lags.
Zumiez (ZUMZ) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Zumiez (ZUMZ) delivered earnings and revenue surprises of 100% and 0.19%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?
Torrid Holdings (CURV) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Torrid Holdings (CURV) delivered earnings and revenue surprises of -133.33% and 6.73%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?
Zumiez to Unveil Q3 Earnings: What Investors Need to Know
by Zacks Equity Research
ZUMZ's focus on customer-centric growth, strategic global expansion and technology investments positions it for improved profitability and steady sales growth.
Why Zumiez Might Be Your Next Value Pick: Key Insights for Investors
by Zacks Equity Research
ZUMZ's strategic initiatives, including cost optimization and productivity improvements, highlight its potential for long-term growth in the competitive landscape.
Lands' End Crosses 50-Day Moving Average: Is it Time to Buy LE Stock?
by Sumit Singh
Lands' End's efficient inventory management, product innovation and international market expansion position it for sustained progress.
Spartan Stores (SPTN) Q3 Earnings Match Estimates
by Zacks Equity Research
Spartan Stores (SPTN) delivered earnings and revenue surprises of 0% and 0.66%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Why Zumiez (ZUMZ) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Lands' End Up 13% in a Month: Is Now the Moment to Invest In LE Stock?
by Sumit Singh
Lands' End is set to deliver impressive returns, driven by its strategic focus on innovation and customer engagement in a competitive landscape.
ZUMZ Stock Trading Above 200 & 100-Day SMA: What's Next for Investors?
by Zacks Equity Research
Zumiez demonstrates solid technical performance, effective cost management and growth in private label offerings, positioning it for steady growth.
Zumiez Stock Surges 48% in Six Months: Lock in Gains or Invest More?
by Zacks Equity Research
ZUMZ offers an attractive investment opportunity with its strong financial performance, strategic focus on private label growth and operational efficiency.
Zumiez Inc. (ZUMZ) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Zumiez (ZUMZ) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.